Evidence map›Paper›PMID 37300874›Full record

ReviewFEMS microbiology reviews2023

After a century of nisin research - where are we now?

Des Field, Miguel Fernandez de Ullivarri, R Paul Ross, Colin Hill

Open access · hybridAbstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Association of D-limonene and nisin: the action on vegetative cells and spores of Alicyclobacillus spp. in processed orange juice.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Probiotics and Fermented Foods in Human Nutrition.Molecules (Basel, Switzerland) · 2026
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Bioprotective Effect of a Bacteriocin-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Des FieldAPC Microbiome Ireland, University College Cork,Western Road, Cork T12 YN60, Ireland.
Miguel Fernandez de UllivarriAPC Microbiome Ireland, University College Cork,Western Road, Cork T12 YN60, Ireland.
R Paul RossAPC Microbiome Ireland, University College Cork,Western Road, Cork T12 YN60, Ireland.
Colin HillAPC Microbiome Ireland, University College Cork,Western Road, Cork T12 YN60, Ireland.ORCID 0000-0003-4425-5817
University College Cork · IE

Funding

Science Foundation Ireland SFI/12/RC/2273
6 · The paper itself

Abstract

It is almost a century since nisin was discovered in fermented milk cultures, coincidentally in the same year that penicillin was first described. Over the last 100 years this small, highly modified pentacyclic peptide has not only found success in the food industry as a preservative but has also served as the paradigm for our understanding of the genetic organization, expression, and regulation of genes involved in lantibiotic biosynthesis-one of the few cases of extensive post-translation modification in prokaryotes. Recent developments in understanding the complex biosynthesis of nisin have shed light on the cellular location of the modification and transport machinery and the co-ordinated series of spatio-temporal events required to produce active nisin and provide resistance and immunity. The continued unearthing of new natural variants from within human and animal gastrointestinal tracts has sparked interest in the potential application of nisin to influence the microbiome, given the growing recognition of the role the gastrointestinal microbiota plays in health and disease. Moreover, interdisciplinary approaches have taken advantage of biotechnological advancements to bioengineer nisin to produce novel variants and expand nisin functionality for applications in the biomedical field. This review will discuss the latest progress in these aspects of nisin research.

Indexed as

BacteriocinsLactococcus lactisNisinAnti-Bacterial AgentsHumansPenicillinsProtein Processing, Post-TranslationalAnti-Bacterial AgentsBacteriocinsNisinPenicillinsantibiotic resistanceantimicrobialbioengineeringlantibioticmicrobiomenisin

Identifiers

PMID37300874
PMCPMC10257480
OpenAlexW4376225799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.